센티 바이오사이언시스 (SNTI)

Mar 01, 2025

Comparing Senti Biosciences (NASDAQ:SNTI) and Windtree Therapeutics (NASDAQ:WINT) - Defense World

Mar 01, 2025

Feb 28, 2025

NK Cell Therapy Market on Track for Exponential Growth Amid Rising Pipeline Developments | DelveInsight - GlobeNewswire Inc.

Feb 28, 2025

Feb 25, 2025

Senti Biosciences Appoints New CFO Jay Cross - TipRanks

Feb 25, 2025

Feb 25, 2025

Senti Bio appoints Jay Cross as CFO - TipRanks

Feb 25, 2025

Feb 25, 2025

Senti Biosciences expands leadership with new CFO and SVP By Investing.com - Investing.com Canada

Feb 25, 2025

Feb 25, 2025

Senti Biosciences expands leadership with new CFO and SVP - Investing.com India

Feb 25, 2025

Feb 25, 2025

Senti Bio Strengthens Leadership Team with Strategic Hires - The Manila Times

Feb 25, 2025

Feb 25, 2025

Can Senti Bio's New Executives Accelerate Its Novel Cell Therapy Programs? - StockTitan

Feb 25, 2025

Feb 25, 2025

Senti Biosciences (SNTI) Stock Price, News & Analysis - MarketBeat

Feb 25, 2025

Feb 20, 2025

Senti Biosciences (NASDAQ:SNTI) versus IN8bio (NASDAQ:INAB) Critical Contrast - Defense World

Feb 20, 2025

Feb 08, 2025

Senti Biosciences CEO Timothy Lu sells shares worth $18,338 - MSN

Feb 08, 2025

Feb 08, 2025

Senti Biosciences executive sells $6,074 in stock - MSN

Feb 08, 2025

Feb 06, 2025

Senti Biosciences Renews Consulting Agreement with Yvonne Li - TipRanks

Feb 06, 2025

Feb 06, 2025

Senti Biosciences CFO transitions to consultant role - Investing.com

Feb 06, 2025

Feb 06, 2025

Senti Biosciences CFO transitions to consultant role By Investing.com - Investing.com UK

Feb 06, 2025

Jan 23, 2025

US Penny Stocks To Watch In January 2025 - Yahoo Finance

Jan 23, 2025

Jan 23, 2025

Critical Comparison: Senti Biosciences (NASDAQ:SNTI) and Ginkgo Bioworks (NYSE:DNA) - Defense World

Jan 23, 2025

Jan 06, 2025

Senti Bio Announces Additional $11.5 Million of Financing - The Manila Times

Jan 06, 2025

Jan 06, 2025

Senti Biosciences secures additional $10 million investment By Investing.com - Investing.com

Jan 06, 2025

Jan 06, 2025

Senti Bio announces additional $11.5M in financing - TipRanks

Jan 06, 2025

Jan 06, 2025

Senti Bio Secures $11.5M Boost: Extends Cash Runway to 2026 with New Funding Round - StockTitan

Jan 06, 2025

Jan 01, 2025

How Is The Market Feeling About Senti Biosciences? - Benzinga

Jan 01, 2025

Dec 28, 2024

Sangamo Therapeutics (NASDAQ:SGMO) & Senti Biosciences (NASDAQ:SNTI) Head-To-Head Comparison - Defense World

Dec 28, 2024

Dec 19, 2024

Comparing VectivBio (NASDAQ:VECT) and Senti Biosciences (NASDAQ:SNTI) - Defense World

Dec 19, 2024

Dec 17, 2024

Senti Biosciences (NASDAQ:SNTI) & BioNTech (NASDAQ:BNTX) Head to Head Review - Defense World

Dec 17, 2024

Dec 16, 2024

Senti Bio Launches Groundbreaking CAR-NK Cell Therapy Trial for Liver Cancer in China - StockTitan

Dec 16, 2024

Dec 16, 2024

Senti Bio Announces First Patient Dosed in Clinical Trial of SN301A in Hepatocellular Carcinoma in Collaboration with Celest Therapeutics - Yahoo Finance

Dec 16, 2024

Dec 10, 2024

Cathie Wood's ARK buys Tempus AI stock, sheds Senti Biosciences - Investing.com India

Dec 10, 2024

Dec 09, 2024

Cathie Wood's ARK buys Tempus AI stock, sheds Senti Biosciences By Investing.com - Investing.com Nigeria

Dec 09, 2024

Dec 09, 2024

Chardan Capital Has Negative Outlook of SNTI FY2024 Earnings - Defense World

Dec 09, 2024

Dec 06, 2024

SNTI Stock Price and Chart — NASDAQ:SNTI - TradingView

Dec 06, 2024

Dec 05, 2024

Senti Bio price target raised to $12 from $10 at Chardan - Yahoo Finance

Dec 05, 2024

Dec 04, 2024

Senti Biosciences Skyrockets 400% On Oversubscribed PIPE Deal, Promising Cancer Trial Data: Retail Overjoyed - MSN

Dec 04, 2024

Dec 04, 2024

Chardan lifts Senti Biosciences stock target on positive trial data By Investing.com - Investing.com Nigeria

Dec 04, 2024

Dec 04, 2024

Chardan lifts Senti Biosciences stock target on positive trial data - Investing.com

Dec 04, 2024

Dec 04, 2024

SNTI Stock Skyrockets on Initial Data From Phase I Cancer Study - MSN

Dec 04, 2024

Dec 04, 2024

Senti Biosciences Announces New Employment Inducement Grants - The Manila Times

Dec 04, 2024

Dec 03, 2024

Senti Biosciences Approves New Employee Stock Options in Latest Inducement Grants - StockTitan

Dec 03, 2024

Dec 03, 2024

Stock market news: Sharps Technology -34.40%, Senti Biosciences -28.60% among biggest losers during mid day trading - Business Upturn

Dec 03, 2024

Dec 03, 2024

Stock market news: Exicure -34.53%, Senti Biosciences -23.70% among biggest losers in early trading - Business Upturn

Dec 03, 2024

Dec 03, 2024

Senti Bio reports positive initial clinical data from Phase 1 trial of SENTI-202 - Yahoo Finance

Dec 03, 2024

Dec 03, 2024

Senti Biosciences reports early success in AML trial - The Pharma Letter

Dec 03, 2024

Dec 03, 2024

Senti Bio appoints new board member and audit chair By Investing.com - Investing.com Canada

Dec 03, 2024

Dec 03, 2024

Senti Biosciences, Inc. announced that it expects to receive $37.60425 million in funding from Celadon Partners, New Enterprise Associates, Inc., Leaps by Bayer, Nantahala Capital Management, LLC and other investors - Marketscreener.com

Dec 03, 2024

Dec 02, 2024

Senti Biosciences, Inc. (SNTI) could keep surging and here’s why - BP Journal

Dec 02, 2024

Dec 02, 2024

Senti Biosciences Advances with Key Financial and Strategic Moves - TipRanks

Dec 02, 2024